信念医药
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Belief BioMed to Collaborate with AskBio to Explore the Potential of New Gene Therapies 2024-09-25 14:58
Belief BioMed Successfully Completed Dosing of First Subject in the Registrational Clinical Trial for Hemophilia A 2024-01-03 18:10
Belief BioMed Announces a Key Milestone of Dosing Completion for All Subjects in its Registrational Clinical Trial of BBM-H901 2023-04-24 10:23
Clinical trial results of Belief BioMed's hemophilia B gene therapy drug candidate BBM-H901 published in The Lancet Haematology 2022-05-20 10:43
Belief Biomed's Gene Therapy for Hemophilia B Receives NMPA IND Approval: First Intravenous Infusion Gene Therapy for Rare Disease in China 2021-08-10 23:39
1